155 related articles for article (PubMed ID: 2354451)
1. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
Verdonck LF; Witteveen EO; van Heugten HG; Rozemuller E; Rijksen G
Cancer Res; 1990 Jul; 50(13):4020-5. PubMed ID: 2354451
[TBL] [Abstract][Full Text] [Related]
2. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
3. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
[TBL] [Abstract][Full Text] [Related]
5. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
6. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
Estrov Z; Freedman MH
Cancer Res; 1988 Oct; 48(20):5901-7. PubMed ID: 3048651
[TBL] [Abstract][Full Text] [Related]
7. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies.
el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
[TBL] [Abstract][Full Text] [Related]
9. The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells.
Vogler WR; Whigham EA; Somberg LB; Long RC; Winton EF
Exp Hematol; 1984 Aug; 12(7):569-74. PubMed ID: 6540197
[TBL] [Abstract][Full Text] [Related]
10. Heterogenous response of primary cultured bone marrow cells of patients with different varieties of leukemia to differentiation inducers.
Chen ZX; Wang W; Wu WL
Chin Med J (Engl); 1989 Mar; 102(3):174-82. PubMed ID: 2503303
[TBL] [Abstract][Full Text] [Related]
11. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
[TBL] [Abstract][Full Text] [Related]
12. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
[TBL] [Abstract][Full Text] [Related]
13. Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases.
Coulombel L; Eaves C; Kalousek D; Gupta C; Eaves A
J Clin Invest; 1985 Mar; 75(3):961-9. PubMed ID: 3856572
[TBL] [Abstract][Full Text] [Related]
14. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC
Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
[No Abstract] [Full Text] [Related]
16. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
Kramer B; Makrynikola V; Bradstock K
Prog Clin Biol Res; 1992; 377():41-7. PubMed ID: 1438438
[No Abstract] [Full Text] [Related]
17. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
18. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
Makrynikola V; Kabral A; Bradstock KF
Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
[TBL] [Abstract][Full Text] [Related]
19. Polymerase chain reaction: a method for monitoring tumor cell purge by long-term culture in BCR/ABL positive acute lymphoblastic leukemia.
Fabrega S; Laporte JP; Giarratana MC; Douay L; Fouillard L; Da WM; Perrot C; Barbu V; Gorin NC
Bone Marrow Transplant; 1993 Feb; 11(2):169-73. PubMed ID: 8435666
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]